Company intelligence / Profile preview
Can-Fite BioPharma Ltd.
Petah Tikva/Ramat Gan, Israelcanfite.com ↗
- Ownership
- Public · CANF
- Development stage
- Phase 3
01
Overview
Can-Fite has multiple drugs in clinical development. Piclidenoson has initiated a pivotal Phase III trial for psoriasis with FDA and EMA-approved protocol. Namodenoson is enrolling patients for a pivotal Phase III study in advanced liver cancer and has received Orphan Drug Designation in the U.S. and Europe and Fast Track Designation as a second-line treatment for HCC. A Phase IIa study for pancreatic cancer is starting enrollment, and a Phase IIb study for MASH is ongoing. The company is also initiating a Phase II study for Piclidenoson in Lowe Syndrome.[1][2][6][9]
- Therapeutic areas
- GastroenterologyMen's HealthDermatologyOncologyRare Diseases
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →03
Partnerships
Cipher Pharmaceuticals (Canada)Gebro Pharma GmbH (Spain, Switzerland & Austria)Kyongbo Pharm (Korea)CMS (China, Taiwan, Hong Kong, Macao)Chong Kun Dang Pharmaceutical (Korea)Fondazione Telethon (Italy)
04
Financials
- Market cap
- $2.8M
- Total revenue
- $101.5K
- Enterprise value
- $-5.6M
Beyond the preview
Go deeper on Can-Fite BioPharma Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Can-Fite BioPharma Ltd..